Land: Australien
Språk: engelska
Källa: APVMA (Australian Pesticides and Veterinary Medicines Authority)
LEPTOSPIRA ICTEROHAEMORRHAGIAE ANTIGEN; CANINE CORONAVIRUS VACCINE - ANTIGEN
Boehringer Ingelheim Animal Health Australia Pty. Ltd.
canine coronavirus+vaccine - leptospirosis
MISC. VACCINES OR ANTI SERA
LEPTOSPIRA ICTEROHAEMORRHAGIAE ANTIGEN VACCINE-ANTIGEN Active 1.0 RP; CANINE CORONAVIRUS VACCINE - ANTIGEN VACCINE-VIRAL Active 1.62 RP
10 x 1mL; 25 x 1mL
VM - Veterinary Medicine
DOG - OVER 6 WEEKS OLD
IMMUNOTHERAPY
CANINE ADENOVIRUS - TYPE 1 | CANINE ADENOVIRUS - TYPE 2 | CANINE CORONAVIRUS | CANINE DISTEMPER | CANINE PARAINFLUENZA | CANINE PARVOVIRUS | LEPTOSPIRA ICTEROHAEMORRHAGIAE | PARVOVIRUS
Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: DOG - OVER 6 WEEKS OLD: [CANINE ADENOVIRUS - TYPE 1, CANINE ADENOVIRUS - TYPE 2, CANINE CORONAVIRUS, CANINE DISTEMPER, CANINE PARAINFLUENZA, CANINE PARVOVIRUS, LEPTOSPIRA ICTEROHAEMORRHAGIAE]; For the immunisation of healthy dogs, 6 weeks of age or older to protect against disease caused by Leptospira copenhageni and aid in protection against disease caused by canine coronavirus.Can be used for prevention of clinical disease, however, it may fail to prevent infection or organism shedding. See DIRECTIONS FOR USE, PRECAUTIONS and SIDE EFFECTS information on label.
Registered
2023-07-01
Protech C2i Canine Coronavirus & Leptospira Copenhageni Killed Vaccine APVMA51488 Page 1 of 5 11 October 2013 Vial label FOR ANIMAL TREATMENT ONLY PROTECH® C2I CANINE CORONAVIRUS & LEPTOSPIRA COPENHAGENI KILLED VACCINE READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. Store between 2-8°C. Do not freeze. Protect from light. APVMA 51488/60396 Batch No.: Expiry: Boehringer lngelheim RLP Approved Protech C2i Canine Coronavirus & Leptospira Copenhageni Killed Vaccine APVMA 51488 Page 2 of 5 11 October 2013 Tray label- 10 FOR ANIMAL TREATMENT ONLY PROTECH® C2I CANINE CORONAVIRUS & LEPTOSPIRA COPENHAGENI KILLED VACCINE An inactivated vaccine prepared from virulent canine coronav irus (RP ~ 1.62) and bacterins of Leptospira interrogans serovar Copenhageni (RP ~ 1.0). For the immunisation of healthy dogs, 6 weeks of age or older to protect aga i nst disease caused by Leptospira interrogans serovar Copenhageni and aid in protection against disease caused by canine coronav irus. Contents : 10 single dose vials READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. Store between 2-8°C. Do not freeze. Protect from light. APVMA No 51488/ 60396 Batch No .: Expiry: Protech® C2i is a registered trademark of Boehr i nger lnge lheim Vetmedica Inc. - used under license. Please recycle leaflet, label and tray only . Boehringer lngelheim ' Protech C2i Canine Coronavirus & Leptospira Copenhageni Killed Vaccine APVMA51488 Page 3 of 5 11 October 2013 Tray label- 25 FOR ANIMAL TREATMENT ONLY PROTECH® C2I CANINE CORONAVIRUS & LEPTOSPIRA COPENHAGENI KILLED VACCINE An inactivated vaccine prepared from virulent canine coronavirus (RP <: 1.62) and bacterins of Leptospira interrogans serovar Copenhageni (RP <: 1.0). For the immunisation of healthy dogs, 6 weeks of age or older to protect against disease caused by Leptospira interrogans serovar Copenhageni and aid in protection against disease caused by canine coronavirus. Contents: 25 single dose vials READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT Store between 2-8"C. Do not freeze Läs hela dokumentet
CS: 1.7.2 Page: 1 MATERIAL SAFETY DATA SHEET 4 of Infosafe No™ LQ08A August 2011 ISSUED by BOEHRING Issue Date : PROTECH C2I Product Name : Not classified as hazardous 1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER PROTECH C2I PRODUCT NAME Boehringer Ingelheim Pty. Limited COMPANY NAME 78 Waterloo Rd North Ryde NSW 2113 Australia ADDRESS 1800 038 037 EMERGENCY TEL. Tel: 1800 038 037 Fax: +61 2 8875 8715 TELEPHONE/FAX NUMBER animalhealth.au@boehringer-ingelheim.com EMAIL An inactivated vaccine for the immunisation of healthy dogs, 6 weeks of age or older to protect against disease caused by Leptospira interrogans serovar Copenhageni and aid in protection against disease caused by canine coronavirus. RECOMMENDED USE 2. HAZARDS IDENTIFICATION Not classified as hazardous NON-HAZARDOUS SUBSTANCE. NON-DANGEROUS GOODS. Hazard classification according to the criteria of NOHSC. Dangerous goods classification according to the Australia Dangerous Goods Code. HAZARD CLASSIFICATION 3. COMPOSITION/INFORMATION ON INGREDIENTS An inactivated vaccine prepared from virulent canine coronavirus (CCV-TN449 strain, RP . 1.62) and bacterins of Leptospira interrogans serovar Copenhageni. INFORMATION ON COMPOSITION NAME CAS PROPORTION INGREDIENTS Ingredients determined not to be hazardous - 100 % 4. FIRST AID MEASURES No special precautions required. However, if inhaled, remove affected person from contaminated area. Keep at rest until recovered. If symptoms persist seek medical attention. INHALATION Do not induce vomiting. Wash out mouth thoroughly with water. If symptoms develop seek medical attention. INGESTION Wash affected area thoroughly with soap and water. If symptoms develop seek medical attention. Self-Injection: Accidental self injection may lead to an inflammatory response and medical advice should be sought on the management of deep injections, particularly those near a joint or associated with bruising. If possible the application of gentle squeezing pressure with absorbent material (e.g. facial tissues) at the injection s Läs hela dokumentet